Örebro University Hospital

Running trials

• Not yet recruiting

  A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)

  NCT07915219· Phase 3· Boehringer Ingelheim· Source

• Not yet recruiting

  Prophylactic Treatment of Graves Ophthalmopathy (GO) in Newly Diagnosed Graves' Disease (GD) With Atorvastatin (ATORGO)

  NCT07883356· Phase 2· Region Skane· Source

• Not yet recruiting

  RBD1119 in Coronary Artery Disease (CAD)

  NCT07884136· Phase 2· Ribocure Pharmaceuticals AB· Source

• Recruiting

  A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active conventional therapy versus three biologic treatments, and two de-escalation strategies in patients who respond to treatment.

  NCT01491815· Phase 4· Karolinska Institutet· Source

• Not yet recruiting

  REcovery After Cancer Application

  NCT07642492· Karolinska Institutet· Source

• Recruiting

  Prospective Risk Evaluation and Detection of Crohn's Disease in First-degree Relatives

  NCT07316621· GLSMED Learning Health S.A.· Source

• Recruiting

  Selenium Intervention Registry Randomized Trial in Heart Failure

  NCT07543562· Phase 3· Skane University Hospital· Source

• Recruiting

  Fusion Imaging in Endovascular Thrombectomy for Acute Ischemic Stroke

  NCT06975696· Region Skane· Source

• Not yet recruiting

  The Örebro Severe Traumatic Brain Injury Registry

  NCT07398274· András Zoltán Buki· Source

• Recruiting

  Intraperitoneal Paclitaxel and Systemic Therapy Versus Systemic Therapy Alone in Gastric Cancer Patients With Peritoneal Metastasis

  NCT07304271· Phase 3· Magnus Nilsson· Source

• Recruiting

  A phase 3 multicenter, randomised, prospective, open-label trial of fixed-duration (12 cycles) venetoclax/ obinutuzumab vs. fixed-duration (15 cycles) venetoclax/ pirtobrutinib vs. MRD-guided venetoclax/ pirtobrutinib in patients with previously untreated chronic lymphocytic leukaemia (CLL)/ small lymphocytic lymphoma (SLL) aiming to establish measurement of individual residual disease for adjustment of treatment duration to improve outcomes (CLL18/ MOIRAI)

  2023-510294-34-00· Phase 3· University Of Cologne· Source

• Recruiting

  The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

  NCT06872892· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

  NCT06499285· Phase 3· Takeda· Source

• Recruiting

  Treatment With Auricular Vagus Nerve Stimulation in Rheumatoid Arthritis - the TRAVAGA Study

  NCT06779123· taVNS AB· Source

• Recruiting

  Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

  NCT06419946· Phase 3· Vastra Gotaland Region· Source

• Recruiting

  Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).

  NCT06641414· Phase 3· Ascentage Pharma Group Inc.· Source

• Recruiting

  International Care Bundle Evaluation in Cerebral Hemorrhage Research

  NCT06429332· Phase 4· Region Skane· Source

• Active, not recruiting

  Internet-based Support for Informal Caregivers of Patients With Head and Neck Cancer - Carer eSupport

  NCT06307418· Uppsala University· Source

• Active, not recruiting

  PreVent-ACaLL

  NCT03868722· Phase 2· Rigshospitalet· Source

• Recruiting

  Effect of HIgh-flow Therapy in Long-term Oxygen Therapy

  NCT06247397· Skane University Hospital· Source

• Recruiting

  Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC)

  NCT06401616· Phase 4· Odense University Hospital· Source

• Recruiting

  Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients

  NCT06044623· Phase 3· Region Örebro County· Source

• Recruiting

  a Multicentre Phase III Study of Risk-based Treatment Intensification With Hyperfractionated Radiotherapy in Head and Neck Cancer Patients

  NCT06248996· Phase 3· Lund University Hospital· Source

• Not yet recruiting

  Surveillance After Resection of Oesophageal aNd Gastric Cancer (SARONG-II) Trial

  NCT06115629· Phase 3· University of Dublin, Trinity College· Source

• Recruiting

  DESTINY Breast Respond HER2-(Ultra)Low Europe

  NCT05945732· Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company· Source

• Recruiting

  Robotic Assisted Surgery In Total Knee Replacement

  NCT05842538· Sahlgrenska University Hospital· Source

• Recruiting

  Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation

  NCT05679024· Phase 3· Region Stockholm· Source

• Recruiting

  Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer

  NCT05448547· Phase 3· Sven Löffeler· Source

• Recruiting

  Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer

  NCT05377047· Phase 3· Vastra Gotaland Region· Source

• Active, not recruiting

  COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events

  NCT05333068· Diagram B.V.· Source

• Recruiting

  Lymphedema After Urologic Surgery

  NCT05264337· Vastra Gotaland Region· Source

• Active, not recruiting

  Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer

  NCT05169567· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  HELicobacter Pylori Screening to Prevent Gastrointestinal Bleeding in Patients With Acute Myocardial Infarction

  NCT05024864· Karolinska Institutet· Source

• Active, not recruiting

  Effects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI

  NCT03620266· Ole Frobert, MD, PhD· Source

• Recruiting

  Assessment of Anorectal Function in Patients With Inflammatory Bowel Disease

  NCT05185609· Region Örebro County· Source

• Active, not recruiting

  A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice

  NCT05049798· Janssen Pharmaceutica N.V., Belgium· Source

• Enrolling by invitation

  Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting

  NCT04451044· Philips Clinical & Medical Affairs Global· Source

• Active, not recruiting

  Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE Project

  NCT04879563· Phase 2· Region Örebro County· Source

• Active, not recruiting

  Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With Myelofibrosis

  NCT04454658· Phase 1· AbbVie· Source

• Active, not recruiting

  Physical Exercise for Treatment of Depression and Anxiety - RCT

  NCT04714528· Region Örebro County· Source

• Active, not recruiting

  Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)

  NCT04562805· Elixir Medical Corporation· Source

• Active, not recruiting

  Treatment of Distal Malignant Biliary Obstruction by Uncovered, Partially Covered, or Fully Covered Metal Stents

  NCT06453590· Region Stockholm· Source

• Recruiting

  A Study in Leukemia Patients With Karonudib

  NCT04077307· Phase 1· Thomas Helleday Foundation· Source

• Active, not recruiting

  Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer

  NCT04114825· Phase 2· RhoVac APS· Source

• Recruiting

  Optimal Electrical Stimulus During Electroconvulsive Therapy

  NCT04057378· Phase 4· Region Örebro County· Source

• Recruiting

  Clinical Investigation of Proton Treatment in Hodgkin Lymphoma Patients - PRO-Hodgkin

  NCT06883604· Uppsala University Hospital· Source

• Active, not recruiting

  Genetic Causes of Familial Hypercholesterolemia

  NCT04101149· Region Örebro County· Source

• Active, not recruiting

  A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy

  NCT03675308· Phase 3· AbbVie· Source

• Active, not recruiting

  A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)

  NCT03671148· Phase 3· AbbVie· Source

• Active, not recruiting

  Ixazomib Plus Lenalidomide Plus Dexamethasone for Newly Diagnosed Myeloma Patients

  NCT03376672· Phase 2· Raija Silvennoinen· Source

Showing 50 of 59.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Stroke4 recruiting
• Gastric and oesophageal cancer3 recruiting
• Metastatic breast cancer3 recruiting
• Prostate cancer3 recruiting
• Atrial fibrillation2 recruiting
• Chronic lymphocytic leukaemia2 recruiting
• Coronary artery disease2 recruiting
• Myelodysplastic syndromes2 recruiting
• Rheumatoid arthritis2 recruiting
• Bipolar disorder1 recruiting
• Bladder cancer1 recruiting
• Bronchiectasis1 recruiting
• Chronic kidney disease1 recruiting
• COPD1 recruiting
• Crohn's disease1 recruiting
• Glioblastoma1 recruiting
• Graves' disease and hyperthyroidism1 recruiting
• Head and neck cancer1 recruiting
• Heart failure1 recruiting
• Hodgkin lymphoma1 recruiting
• Irritable bowel syndrome1 recruiting
• Melanoma1 recruiting
• Multiple myeloma1 recruiting
• Osteoarthritis1 recruiting

Closed trials

• Completed

  Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)

  NCT06122961· Novo Nordisk A/S· Source

• Completed

  InPen User Experience

  NCT05029271· Medtronic MiniMed, Inc.· Source

• Completed

  Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever

  NCT05152524· Rapid Medical· Source

• Completed

  NORDTREAT Prospective Study on Inflammatory Bowel Disease

  NCT05414578· University of Southern Denmark· Source

• Completed

  The Nordic IBD Treatment Strategy Trial

  NCT05180175· Phase 4· Region Örebro County· Source

• Terminated

  The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

  NCT04985968· Phase 3· InDex Pharmaceuticals· Source

• Completed

  Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis

  NCT04472598· Phase 3· AbbVie· Source

• Completed

  Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of Ulcerative Colitis In Clinical Practice In Sweden

  NCT04338204· Pfizer· Source

• Completed

  Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus Global

  NCT04236609· Concept Medical Inc.· Source

• Recruiting

  A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

  NCT03911128· Mats Heyman· Source

• Completed

  Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

  NCT03473223· Phase 3· CSL Behring· Source

• Completed

  TIMING of Oral Anticoagulant Therapy in Acute Ischemic Stroke With Atrial Fibrillation

  NCT02961348· Uppsala University· Source

• Completed

  Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction

  NCT00673842· Phase 3· University of Calgary· Source

• Completed

  Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma

  NCT01208766· Phase 3· Stichting Hemato-Oncologie voor Volwassenen Nederland· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Coeliac disease11 works · 0 trials